Proteomic profiling of halloysite clay nanotube exposure in intestinal cell co-culture

Journal of Applied Toxicology

Volumn 33, Issue 11, 2013, Pages 1316-1329

  Lai, Xianyin ^a   Agarwal, Mangilal ^b   Lvov, Yuri M ^c   Pachpande, Chetan ^d   Varahramyan, Kody ^b   Witzmann, Frank A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Indiana University Purdue University Indianapolis   (United States)

^c LOUISIANA TECH UNIVERSITY   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

Enterocytes; Halloysite; Intestinal epithelia; Label free quantitative mass spectrometry; Proteomics

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HALLOYSITE; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOTUBE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ALUMINUM SILICATE; CLAY; DRUG CARRIER; PROTEOME;

ADAPTIVE IMMUNITY; ARTICLE; BIOCOMPATIBILITY; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CLAY; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INJURY; INTESTINE EPITHELIUM CELL; LARGE INTESTINE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TOXICITY TESTING; ZETA POTENTIAL; CACO 2 CELL LINE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHEMISTRY; COCULTURE; DRUG EFFECTS; HT 29 CELL LINE; INTESTINE; METABOLISM; PARTICLE SIZE; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY;

ALUMINUM SILICATES; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; COCULTURE TECHNIQUES; DRUG CARRIERS; HT29 CELLS; HUMANS; INTESTINES; MICROSCOPY, ELECTRON, TRANSMISSION; NANOTUBES; PARTICLE SIZE; PROTEOME; PROTEOMICS; SURFACE PROPERTIES;

EID: 84884701716     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2858     Document Type: Article

References (68)

1. Abdullayev E, Joshi A, Wei W, Zhao Y, Lvov Y. 2012. Enlargement of halloysite clay nanotube lumen by selective etching of aluminum oxide. ACS Nano 6: 7216-7226.
2. Ansari KI, Mishra BP, Mandal SS. 2009. MLL histone methylases in gene expression, hormone signaling and cell cycle. Front. Biosci. 14: 3483-3495.
3. Arciero JC, Mi Q, Branca MF, Hackam DJ, Swigon D. 2011. Continuum model of collective cell migration in wound healing and colony expansion. Biophys. J. 100: 535-543.
4. Bergin IL, Witzmann FA. 2012. Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int. J. Biomed. Nanosci. Nanotechnol. (in press).
5. Chang C. 2010. The immune effects of naturally occurring and synthetic nanoparticles. J. Autoimmun. 34: J234-J246.
6. Clark KA, O'Driscoll C, Cooke CA, Smith BA, Wepasnick K, Fairbrother DH, Lees PSJ, Bressler JP. 2011. Evaluation of the Interactions Between Multiwalled Carbon Nanotubes and Caco-2 Cells. J. Toxicol. Environ. Health A 75: 25-35.
7. Cornejo-Garrido H, Nieto-Camacho A, Gómez-Vidales V, Ramírez-Apan MT, del Angel P, Montoya JA, Domínguez-López M, Kibanova D, Cervini-Silva J. 2012. The anti-inflammatory properties of halloysite. Appl. Clay Sci. 57: 10-16.
8. Dougan S, Kaser A, Blumberg R. 2007. CD1 expression on antigen-presenting cells T cell activation by cd1 and lipid antigens. In Moody DB (ed.). Current Topics in Microbiology and Immunology Vol. 314, Springer: Berlin; 113-141.
9. Edgar R, Domrachev M, Lash AE. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30: 207-210.
10. Forsgren J, Jamstorp E, Bredenberg S, Engqvist H, Stromme M. 2010. A ceramic drug delivery vehicle for oral administration of highly potent opioids. J. Pharm. Sci. 99: 219-226.
11. Galligan CL, Baig E, Bykerk V, Keystone EC, Fish EN. 2007. Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity. Genes Immun. 8: 480-491.
12. Hilgendorf C, Spahn-Langguth H, Regardh CG, Lipka E, Amidon GL, Langguth P. 2000. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J. Pharm. Sci. 89: 63-75.
13. Holm S. 1979. A simple sequentially rejective multiple test procedure. Scand. Stat. Theory Appl. 6: 65-70.
14. Hughes AD, King MR. 2010. Use of naturally occurring halloysite nanotubes for enhanced capture of flowing cells. Langmuir 26: 12155-12164.
15. Imataka H, Olsen HS, Sonenberg N. 1997. A new translational regulator with homology to eukaryotic translation initiation factor 4G. EMBO J. 16: 817-825.
16. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y. 1997. An Nrf2/small Maf heterodimer mediates the induction of phase ii detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236: 313-322.
17. Joussein E, Petit S, Churchman J, Theng B, Righi D, Delvaux B. 2005. Halloysite clay minerals - A review. Clay Miner. 40: 383-426.
18. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF. 1995. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95: 55-65.
19. Kawakami K, Ebara M, Izawa H, Sanchez-Ballester NM, Hill JP, Ariga K. 2012. Supramolecular approaches for drug development. Curr. Med. Chem. 19: 2388-2398.
20. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. 2002. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74: 5383-5392.
21. Kelly HM, Deasy PB, Ziaka E, Claffey N. 2004. Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis. Int. J. Pharm. 274: 167-183.
22. Khurana S, Tomar A, George SP, Wang Y, Siddiqui MR, Guo H, Tigyi G, Mathew S. 2008. Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia. Exp. Cell Res. 314: 530-542.
23. Kim JM, Kim JS, Jung HC, Oh YK, Song IS, Kim CY. 2002. Differential expression and polarized secretion of CXC and CC chemokines by human intestinal epithelial cancer cell lines in response to Clostridium difficile toxin A. Microbiol. Immunol. 46: 333-342.
24. Kommireddy DS, Sriram SM, Lvov YM, Mills DK. 2006. Stem cell attachment to layer-by-layer assembled TiO2 nanoparticle thin films. Biomaterials 27: 4296-4303.
25. Lai X, Bacallao RL, Blazer-Yost BL, Hong D, Mason SB, Witzmann FA. 2008. Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics Clin. Appl. 2: 1140-1152.
26. Lai X, Blazer-Yost BL, Clack JW, Fears SL, Mitra S, Ntim SA, Ringham HN, Witzmann FA. 2013. Protein expression profiles of intestinal epithelial co-cultures after low-level exposure to functionalized carbon nanotubes. Int. J. Biomed. Nanosci. Nanotechnol. (in press).
27. Lai X, Wang L, Tang H, Witzmann FA. 2011. A novel alignment method and multiple filters for exclusion of unqualified peptides to enhance label-free quantification using peptide intensity in LC-MS/MS. J. Proteome Res. 10: 4799-4812.
28. Laurent F, Eckmann L, Savidge TC, Morgan G, Theodos C, Naciri M, Kagnoff MF. 1997. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infect. Immun. 65: 5067-5073.
29. Lee D, Shin C. 2012. MicroRNA-target interactions: new insights from genome-wide approaches. Ann. N. Y. Acad. Sci. 1271: 118-128.
30. Lee SH, McCormick F. 2006. p97/DAP5 is a ribosome-associated factor that facilitates protein synthesis and cell proliferation by modulating the synthesis of cell cycle proteins. EMBO J. 25: 4008-4019.
31. Lesuffleur T, Barbat A, Luccioni C, Beaumatin J, Clair M, Kornowski A, Dussaulx E, Dutrillaux B, Zweibaum A. 1991. Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells. J. Cell Biol. 115: 1409-1418.
32. Lesuffleur T, Porchet N, Aubert JP, Swallow D, Gum JR, Kim YS, Real FX, Zweibaum A. 1993. Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. J. Cell Sci. 106 (Pt 3): 771-783.
33. Li PR, Wei JC, Chiu YF, Su HL, Peng FC, Lin JJ. 2010. Evaluation on cytotoxicity and genotoxicity of the exfoliated silicate nanoclay. ACS Appl. Mater. Interfaces 2: 1608-1613.
34. Lordan S, Higginbotham CL. 2012. Effect of serum concentration on the cytotoxicity of clay particles. Cell Biol. Int. 36: 57-61.
35. Lordan S, Kennedy JE, Higginbotham CL. 2011. Cytotoxic effects induced by unmodified and organically modified nanoclays in the human hepatic HepG2 cell line. J. Appl. Toxicol. 31: 27-35.
36. Lütcke H. 1995. Signal Recognition Particle (SRP), a ubiquitous initiator of protein translocation. Eur. J. Biochem. 228: 531-550.
37. Mahler GJ, Esch MB, Glahn RP, Shuler ML. 2009a. Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity. Biotechnol. Bioeng. 104: 193-205.
38. Mahler GJ, Shuler ML, Glahn RP. 2009b. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability. J. Nutr. Biochem. 20: 494-502.
39. Makrodouli E, Oikonomou E, Koc M, Andera L, Sasazuki T, Shirasawa S, Pintzas A. 2011. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study. Mol. Cancer 10: 118.
40. McMahon M, Itoh K, Yamamoto M, Chanas SA, Henderson CJ, McLellan LI, Wolf CR, Cavin C, Hayes JD. 2001. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 61: 3299-3307.
41. Millard TH, Dawson J, Machesky LM. 2007. Characterisation of IRTKS, a novel IRSp53/MIM family actin regulator with distinct filament bundling properties. J. Cell Sci. 120 (Pt 9): 1663-72.
42. Monroe ME, Shaw JL, Daly DS, Adkins JN, Smith RD. 2008. MASIC: a software program for fast quantitation and flexible visualization of chromatographic profiles from detected LC-MS(/MS) features. Comput. Biol. Chem. 32: 215-217.
43. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. 2003. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75: 4646-4658.
44. Nordberg J, Arnér ESJ. 2001. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31: 1287-1312.
45. Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, Suzuki T, Kobayashi A, Yokota J, Sakiyama T, Shibata T, Yamamoto M, Hirohashi S. 2008. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 68: 1303-1309.
46. Osburn WO, Kensler TW. 2008. Nrf2 signaling: An adaptive response pathway for protection against environmental toxic insults. Mutat. Res. 659: 31-39.
47. Park SK, Lee CW, Lee MY. 2008. Inhibitory effect of ore minerals on the allergic inflammation in mouse. J. Korean Soc. Appl. Bi. 51: 269-275.
48. Price R, Gaber BP, Lvov Y. 2001. In-vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dineculeotide from halloysite; a cylindrical mineral. J. Microencapsul. 18: 713-722.
49. Saito S, Furuno A, Sakurai J, Sakamoto A, Park H-R, Shin-ya K, Tsuruo T, Tomida A. 2009. Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation. Cancer Res. 69: 4225-4234.
50. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NCT, Schreiber SL, Mellor J, Kouzarides T. 2002. Active genes are tri-methylated at K4 of histone H3. Nature 419: 407-411. http://www.nature.com/nature/journal/v419/n6905/suppinfo/nature01080_S1.html.
51. Shannahan JH, Kodavanti UP, Brown JM. 2012a. Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells. Inhal. Toxicol. 24: 320-339.
52. Shannahan JH, Brown JM, Chen R, Ke PC, Lai X, Mitra S, Witzmann FA. 2012b. Comparison of nanotube-protein corona composition in cell culture media. Small DOI:10.1002/smll.201202243.
53. Sharma AK, Schmidt B, Frandsen H, Jacobsen NR, Larsen EH, Binderup ML. 2010. Genotoxicity of unmodified and organo-modified montmorillonite. Mutat. Res. 700: 18-25.
54. Shchukin DG, Sukhorukov GB, Price RR, Lvov YM. 2005. Halloysite nanotubes as biomimetic nanoreactors. Small 1: 510-513.
55. Shi YF, Tian Z, Zhang Y, Shen HB, Jia NQ. 2011. Functionalized halloysite nanotube-based carrier for intracellular delivery of antisense oligonucleotides. Nanoscale Res. Lett. 6: 608.
56. Storey JD. 2002. A direct approach to false discovery rates. J. Roy. Stat. Soc. B 64: 479-498.
57. Sugita M, Peters PJ, Brenner MB. 2000. Pathways for lipid antigen presentation by CD1 molecules: nowhere for intracellular pathogens to hide. Traffic 1: 295-300.
58. Suh YJ, Kil DS, Chung KS, Abdullayev E, Lvov YM, Mongayt D. 2011. Natural nanocontainer for the controlled delivery of glycerol as a moisturizing agent. J. Nanosci. Nanotechnol. 11: 661-665.
59. Suresh R, Borkar SN, Sawant VA, Shende VS, Dimble SK. 2010. Nanoclay drug delivery system. Int. J. Pharmaceut. Sci. Nanotech. 3: 901-905.
60. Veerabadran NG, Price RR, Lvov YM. 2007. Clay nanotubes for encapsulation and sustained release of drugs. Nano 2: 115-120.
61. Vergaro V, Abdullayev E, Lvov YM, Zeitoun A, Cingolani R, Rinaldi R, Leporatti S. 2010. Cytocompatibility and uptake of halloysite clay nanotubes. Biomacromol. 11: 820-826.
62. Vergaro V, Lvov YM, Leporatti S. 2012. Halloysite clay nanotubes for resveratrol delivery to cancer cells. Macromol. Biosci. 12: 1265-1271.
63. Vingadassalom D, Kazlauskas A, Skehan B, Cheng HC, Magoun L, Robbins D, Rosen MK, Saksela K, Leong JM. 2009. Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin assembly effectors Tir and EspF(U) during pedestal formation. Proc. Natl. Acad. Sci. U. S. A. 106: 6754-6759.
64. Walter E, Janich S, Roessler BJ, Hilfinger JM, Amidon GL. 1996. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J. Pharm. Sci. 85: 1070-1076.
65. Walter P, Blobel G. 1980. Purification of a membrane-associated protein complex required for protein translocation across the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 77: 7112-7116.
66. Wei W, Abdullayev E, Hollister A, Mills D, Lvov YM. 2012. Clay nanotube/poly(methyl methacrylate) bone cement composites with sustained antibiotic release. Macromol. Mater. Eng. 297: 645-653.
67. Worle-Knirsch JM, Pulskamp K, Krug HF. 2006. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 6: 1261-1268.
68. Zapor L, Dzierzawska K. 2012. Toxicity of nanofillers for polymer composites - in vitro studies 30th International Congress on Occupational Health http://icoh.confex.com/icoh/2012/webprogram/Paper7372.html.